Nishinomiya, Japan

Fumiyo Hirota

This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumiyo Hirota. Retrieved from https://idiyas.com/inventor/fumiyo-hirota

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fumiyo Hirota: Innovator in Pharmaceutical Chemistry

Introduction

Fumiyo Hirota is a distinguished inventor based in Nishinomiya, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Hirota holds a patent for Piperidinylpyrimidine derivatives, which are compounds designed to inhibit the production and/or secretion of tumor necrosis factor in patients requiring such intervention. The patent details a compound of formula (1) wherein specific groups are defined to enhance its efficacy in medical applications.

Career Highlights

Hirota is associated with Sumitomo Pharmaceuticals Company Limited, where she has been instrumental in advancing research and development initiatives. Her work focuses on creating innovative solutions for complex health issues, showcasing her commitment to improving patient outcomes.

Collaborations

Throughout her career, Hirota has collaborated with notable colleagues, including Norio Fujiwara and Yutaka Ueda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Fumiyo Hirota's contributions to pharmaceutical chemistry exemplify her dedication to innovation and research. Her work continues to impact the medical field positively, paving the way for future advancements in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…